Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideasPETACH TIKVA, Israel, Oct.

PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

University College Dublin (UCD) researcher Dr. Nicola Fletcher has received a coveted European Research Council (ERC) Synergy ...

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X ...

PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox” or the "Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its ...

University College Dublin (UCD) researcher Dr Nicola Fletcher has received a coveted ERC Synergy Grant for her groundbreaking project NanoX.

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository ...

Dr. Wimpfheimer is the Chief Medical Officer at Nanox and previously held the position of Chief Medical Officer and Head of Product Strategy at Zebra Medical Vision, until its acquisition by Nanox.